Search - tctmd.com

Displaying 81 - 100 of 2772

Sort: Relevancy | Date

Presentation THT 2026

Bioelectric Regulation of Cardiac Remodeling in Heart Failure: Microcurrent Therapy

Presenter: Stefan Anker

March 03, 2026

Presentation THT 2026

Wearable Cardiac Defibrillator for Newly Diagnosed HFrEF: Real World Evidence

Presenter: Marat Fudim

March 03, 2026

Presentation THT 2026

Real-World Outcomes of Eplerenone in Non-Obstructive Hypertrophic Cardiomyopathy

Presenter: Thitiphan Srikulmontri

March 03, 2026

Presentation THT 2026

Impact of Baseline Tricuspid Regurgitation on Outcomes in Heart Failure Patients Undergoing Mitral TEER

Presenter: Thitiphan Srikulmontri

March 03, 2026

Presentation THT 2026

Cardiac Contractility Modulation: Combining CCM and ICD Therapy

Presenter: Nir Uriel

March 03, 2026

Presentation THT 2026

Central Venous Congestion in Transcatheter Tricuspid Repair: Lessons from the TRI.Fr Trial

Presenter: Karl-Philipp Rommel

March 03, 2026

Presentation THT 2026

Barostimulation Therapy for HFrEF

Presenter: Philip Adamson, MD

March 03, 2026

Presentation THT 2026

Atrial Shunt for Heart Failure with Preserved and Mildly Reduced Ejection Fraction: Five-Year Outcomes from the REDUCE LAP-HF II Trial

Presenter: Sanjiv J. Shah

March 03, 2026

Presentation THT 2026

The Lymphatic System as a Target for ADHF

Presenter: Jan Biegus

March 03, 2026

Presentation THT 2026

Artificial Intelligence Meets Real-World Heart Failure: Early Results from the HF-TRACK Trial

Presenter: Shamus Husheer

March 03, 2026

Presentation THT 2026

Reducing Renal Venous Pressure to Improve Urine Output: Overview of Devices, Current Status, and Future Directions

Presenter: Arvind Bhimaraj

March 03, 2026

Presentation THT 2026

Pumps that Increase Renal Arterial Perfusion Pressure: Current Status and Future Directions

Presenter: Robby Wu

March 03, 2026

Presentation THT 2026

Left Atrial To Coronary Sinus Shunting In Heart Failure With Mildly Reduced Or Preserved Ejection Fraction: The ALT FLOW Trial (Early Feasibility Study) 3-Year Results

Presenter: Benjamin Hibbert

March 03, 2026

Presentation THT 2026

Renal Replacement Therapies: Overview of Systems and When to Use Each

Presenter: Wendy McCallum

March 03, 2026

Presentation THT 2026

Noninvasive Fluid Removal for ADHF: Turning Eccrine Glands Into Nephrons

Presenter: Daniel R. Bensimhon

March 03, 2026

Presentation THT 2026

Predictors of Structural Remodeling After TAVR in Moderate Aortic Stenosis with Heart Failure with Reduced Ejection Fraction

Presenter: Afek Kodesh

March 03, 2026

Presentation THT 2026

Early Cardiac Contractility Modulation (CCM) Therapy Use Reduces Heart Failure-Related Hospitalization

Presenter: Daniel Burkhoff

March 03, 2026

Presentation THT 2026

What Needs to be Shown in Studies of ADHF Devices to Gain FDA Approval and Adoption Into Clinical Practice

Presenter: G. Michael Felker

March 03, 2026

Presentation THT 2026

Who is the Ideal Candidate for Device-Based Therapy for ADHF

Presenter: James E. Udelson

March 03, 2026

Presentation THT 2026

Economic Impact of Passive Monitoring in High-Risk Heart Failure: Cost Avoidance Analysis

Presenter: Afnan Tariq

March 03, 2026

Advertisement

Bioelectric Regulation of Cardiac Remodeling in Heart Failure: Microcurrent Therapy

Wearable Cardiac Defibrillator for Newly Diagnosed HFrEF: Real World Evidence

Real-World Outcomes of Eplerenone in Non-Obstructive Hypertrophic Cardiomyopathy

Impact of Baseline Tricuspid Regurgitation on Outcomes in Heart Failure Patients Undergoing Mitral TEER

Cardiac Contractility Modulation: Combining CCM and ICD Therapy

Central Venous Congestion in Transcatheter Tricuspid Repair: Lessons from the TRI.Fr Trial

Barostimulation Therapy for HFrEF

Atrial Shunt for Heart Failure with Preserved and Mildly Reduced Ejection Fraction: Five-Year Outcomes from the REDUCE LAP-HF II Trial

The Lymphatic System as a Target for ADHF

Artificial Intelligence Meets Real-World Heart Failure: Early Results from the HF-TRACK Trial

Reducing Renal Venous Pressure to Improve Urine Output: Overview of Devices, Current Status, and Future Directions

Pumps that Increase Renal Arterial Perfusion Pressure: Current Status and Future Directions

Left Atrial To Coronary Sinus Shunting In Heart Failure With Mildly Reduced Or Preserved Ejection Fraction: The ALT FLOW Trial (Early Feasibility Study) 3-Year Results

Renal Replacement Therapies: Overview of Systems and When to Use Each

Noninvasive Fluid Removal for ADHF: Turning Eccrine Glands Into Nephrons

Predictors of Structural Remodeling After TAVR in Moderate Aortic Stenosis with Heart Failure with Reduced Ejection Fraction

Early Cardiac Contractility Modulation (CCM) Therapy Use Reduces Heart Failure-Related Hospitalization

What Needs to be Shown in Studies of ADHF Devices to Gain FDA Approval and Adoption Into Clinical Practice

Who is the Ideal Candidate for Device-Based Therapy for ADHF

Economic Impact of Passive Monitoring in High-Risk Heart Failure: Cost Avoidance Analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content